About the paper Risk factors of hepatocellular carcinoma in patients with chronic hepatitis C virus infection receiving pegylated interferon ribavirin treatment

Navarro-Yparraguirre M.M.; Arias-Revilla A.O.; Roque-Quezada J.C.E. · Medicina Interna de Mexico (2022) · DOI: 10.24245/mim.v38i2.6966

Instituciones: Universidad Ricardo Palma